Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Standard dose influenza vaccine
BIOLOGICAL
2 trials
Sponsors
Marshfield Clinic Research Foundation
, Korea University Guro Hospital
Conditions
Immune Response
Immunogenicity
Immunosenescence
Influenza Vaccination
Older Adults (65 Years and Older)
Repeated Vaccination
Phase 4
Influenza Vaccine Immunogenicity in Repeatedly Vaccinated Older Adults
Recruiting
NCT07838298
Korea University Guro Hospital
Influenza Vaccination, Older Adults (65 Years and Older), Immunosenescence +2
Start: 2026-09-21
End: 2028-12-01
Target: 180
Updated: 2026-09-24
Unknown Phase
Open-Label Influenza Vaccine Evaluation
Completed
NCT02872311
Marshfield Clinic Research Foundation
Immune Response
Start: 2016-09-30
End: 2018-09-30
Updated: 2025-12-10
Related Papers
Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65–74 years
Vaccine
2021-11-10
5 citations
Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018.
2020-03-04
16 citations